Pekin Hardy Strauss Inc. Sells 701 Shares of Oracle Corporation $ORCL

Pekin Hardy Strauss Inc. trimmed its holdings in shares of Oracle Corporation (NYSE:ORCL) by 38.0% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,145 shares of the enterprise software provider’s stock after selling 701 shares during the quarter. Pekin Hardy Strauss Inc.’s holdings in Oracle were worth $250,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of the business. Mcrae Capital Management Inc. bought a new stake in shares of Oracle during the 2nd quarter worth $217,000. Horizon Investment Services LLC purchased a new stake in Oracle during the second quarter worth about $240,000. OneAscent Family Office LLC increased its holdings in Oracle by 73.1% during the second quarter. OneAscent Family Office LLC now owns 2,990 shares of the enterprise software provider’s stock worth $654,000 after buying an additional 1,263 shares during the last quarter. Soltis Investment Advisors LLC raised its position in Oracle by 4.8% in the second quarter. Soltis Investment Advisors LLC now owns 32,937 shares of the enterprise software provider’s stock worth $7,201,000 after acquiring an additional 1,515 shares during the period. Finally, Souders Financial Advisors boosted its stake in Oracle by 30.6% in the second quarter. Souders Financial Advisors now owns 2,455 shares of the enterprise software provider’s stock valued at $537,000 after acquiring an additional 575 shares during the last quarter. Hedge funds and other institutional investors own 42.44% of the company’s stock.

Oracle Stock Down 1.9%

Shares of NYSE ORCL opened at $239.15 on Friday. The company has a quick ratio of 0.62, a current ratio of 0.62 and a debt-to-equity ratio of 3.33. The company has a market cap of $681.77 billion, a P/E ratio of 55.36, a P/E/G ratio of 2.96 and a beta of 1.51. Oracle Corporation has a 52 week low of $118.86 and a 52 week high of $345.72. The business has a 50-day simple moving average of $279.32 and a two-hundred day simple moving average of $230.60.

Oracle (NYSE:ORCL) last announced its quarterly earnings results on Tuesday, September 9th. The enterprise software provider reported $1.47 earnings per share for the quarter, missing the consensus estimate of $1.48 by ($0.01). Oracle had a net margin of 21.08% and a return on equity of 72.93%. The company had revenue of $14.93 billion for the quarter, compared to the consensus estimate of $15.04 billion. During the same quarter in the prior year, the company earned $1.39 earnings per share. The company’s quarterly revenue was up 12.2% on a year-over-year basis. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. Research analysts anticipate that Oracle Corporation will post 5 earnings per share for the current fiscal year.

Oracle Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, October 23rd. Shareholders of record on Thursday, October 9th were issued a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend was Thursday, October 9th. Oracle’s dividend payout ratio (DPR) is presently 46.30%.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on ORCL shares. JMP Securities reaffirmed a “market outperform” rating and issued a $342.00 price target on shares of Oracle in a report on Friday, October 17th. Sanford C. Bernstein boosted their target price on Oracle from $363.00 to $364.00 and gave the company an “outperform” rating in a research note on Friday, September 26th. Royal Bank Of Canada reaffirmed a “sector perform” rating and set a $310.00 price target on shares of Oracle in a research report on Friday, October 17th. Stephens lifted their price objective on Oracle from $208.00 to $331.00 and gave the stock an “equal weight” rating in a report on Friday, October 17th. Finally, The Goldman Sachs Group restated a “neutral” rating and issued a $320.00 price objective on shares of Oracle in a research note on Monday, October 20th. Three equities research analysts have rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating, ten have issued a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Oracle presently has an average rating of “Moderate Buy” and a consensus target price of $323.69.

Insider Activity

In other news, Director William G. Parrett sold 11,500 shares of the company’s stock in a transaction on Friday, September 12th. The shares were sold at an average price of $306.00, for a total value of $3,519,000.00. Following the transaction, the director owned 17,764 shares of the company’s stock, valued at approximately $5,435,784. This represents a 39.30% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Stuart Levey sold 19,758 shares of Oracle stock in a transaction on Friday, October 10th. The shares were sold at an average price of $300.00, for a total value of $5,927,400.00. Following the sale, the executive vice president directly owned 18,429 shares of the company’s stock, valued at $5,528,700. This represents a 51.74% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 204,254 shares of company stock worth $60,227,807. Company insiders own 40.90% of the company’s stock.

Oracle Company Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.